APC10.1: An ApcMin/+ intestinal cell line with retention of heterozygosity

International Journal of Cancer

Volumn 109, Issue 2, 2004, Pages 200-206

  De Giovanni, Carla ^a,d   Landuzzi, Lorena ^b   Nicoletti, Giordano ^b   Astolfi, Annalisa ^a   Croci, Stefania ^a   Micaroni, Massimo ^c   Nanni, Patrizia ^a   Lollini, Pier Luigi ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^c UNIVERSITY OF CHIETI   (Italy)

^d Cancer Research Center   (Italy)

Author keywords

Adenomatous polyposis coli; ApcMin; Gene expression profile

Indexed keywords

CYTOKERATIN; HEPATOCYTE NUCLEAR FACTOR 3; HEPATOCYTE NUCLEAR FACTOR 3BETA; LAMININ; PROTEIN P21; T CELL FACTOR PROTEIN; UNCLASSIFIED DRUG; WNT PROTEIN; APC PROTEIN; CYTOSKELETON PROTEIN; ONCOPROTEIN; RNA; TRANSCRIPTION FACTOR; ZEBRAFISH PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; COLON POLYPOSIS; CONTROLLED STUDY; GENE EXPRESSION; GENOTYPE; HETEROZYGOSITY; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; INTESTINE CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; REGULATOR GENE; REPORTER GENE; SIGNAL TRANSDUCTION; STEM CELL; UNINDEXED SEQUENCE; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL DIFFERENTIATION; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENETICS; HETEROZYGOTE; INTESTINE TUMOR; METABOLISM; NUDE MOUSE; PATHOLOGY; TUMOR SUPPRESSOR GENE;

ADENOMATOUS POLYPOSIS COLI; ADENOMATOUS POLYPOSIS COLI PROTEIN; ANIMALS; CELL DIFFERENTIATION; CYTOSKELETAL PROTEINS; FEMALE; GENE EXPRESSION PROFILING; GENES, APC; HETEROZYGOTE; INTESTINAL NEOPLASMS; MICE; MICE, INBRED C57BL; MICE, NUDE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENE PROTEINS; RNA, NEOPLASM; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; WNT PROTEINS; ZEBRAFISH PROTEINS;

EID: 1242274496     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.11690     Document Type: Article

References (36)

1. Fodde R, Smits R, Clevers H. APC, signal transduction and genetic instability in colorectal cancer. Nat Rev Cancer 2001;1:55-67.
2. van Es JH, Giles RH, Clevers HC. The many faces of the tumor suppressor gene APC. Exp Cell Res 2001;264:126-34.
3. Fodde R, Smits R. Disease model: familial adenomatous polyposis. Trends Mol Med 2001;7:369-73.
4. Whitehead RH, VanEeden PE, Noble MD, Ataliotis P, Jat PS. Establishment of conditionally immortalized epithelial cell lines from both colon and small intestine of adult H-2Kb-tsA58 transgenic mice. Proc Natl Acad Sci USA 1993;90:587-91.
5. D'Abaco GM, Whitehead RH, Burgess AW. Synergy between Apc min and an activated ras mutation is sufficient to induce colon carcinomas. Mol Cell Biol 1996;16:884-91.
6. Clatworthy JP, Subramanian V. Stem cells and the regulation of proliferation, differentiation and patterning in the intestinal epithelium: emerging insights from gene expression patterns, transgenic and gene ablation studies. Mech Dev 2001;101:3-9.
7. Luongo C, Moser AR, Gledhill S, Dove WF. Loss of Apc+ in intestinal adenomas from Min mice. Cancer Res 1994;54:5947-52.
8. Nanni P, De Giovanni C, Lollini PL, Nicoletti G, Prodi G. TS/A: a new metastasizing cell line from a BALB/c spontaneous mammary adenocarcinoma. Clin Exp Metastasis 1983;1:373-80.
9. Freshney RJ, ed. Culture of animal cells, 4th ed. New York: Wiley-Liss, 2000.
10. Zucchi I, Bini L, Valaperta R, Ginestra A, Albani D, Susani L, Sanchez JC, Liberatori S, Magi B, Raggiaschi R, Hochstrasser DF, Pallini V, et al. Proteomic dissection of dome formation in a mammary cell line: role of tropomyosin-5b and maspin. Proc Natl Acad Sci USA 2001;98:5608-13.
11. Vieira-Coelho MA, Soares-Da-Silva P. Uptake and intracellular fate of L-DOPA in a human intestinal epithelial cell line: Caco-2. Am J Physiol 1998;275:C104-12.
12. Chen X, Halberg RB, Ehrhardt WM, Torrealba J, Dove WF. Clusterin as a biomarker in murine and human intestinal neoplasia. Proc Natl Acad Sci USA 2003;100:9530-5.
13. Kayahara T, Sawada M, Takaishi S, Fukui H, Seno H, Fukuzawa H, Suzuki K, Hiai H, Kageyama R, Okano H, Chiba T. Candidate markers for stem and early progenitor cells, Musashi-1 and Hes1, are expressed in crypt base columnar cells of mouse small intestine. FEBS Lett 2003;535:131-5.
14. De Bruin WC, Te Morsche RH, Wagenmans MJ, Alferink JC, Townsend AJ, Wieringa B, Peters WH. Identification of a novel murine glutathione S-transferase class mu gene. Biochem J 1998;330 (Pt 2):623-6.
15. Guo J, Pal A, Srivastava SK, Orchard JL, Singh SV. Differential expression of glutathione S-transferase isoenzymes in murine small intestine and colon. Comp Biochem Physiol B Biochem Mol Biol 2002;131:443-52.
16. van de Wetering M, Sancho E, Verweij C, de Lau W, Oving I, Hurlstone A, van der Heyden K, Battle E, Coudreuse D, Haramis AP, Tjon-Pon-Fong M, Moerer P, et al. The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 2002;111:241-50.
17. Orner GA, Dashwood WM, Blum CA, Diaz GD, Li Q, Dashwood RH. Suppression of tumorigenesis in the Apc(min) mouse: downregulation of beta-catenin signaling by a combination of tea plus sulindac. Carcinogenesis 2003;24:263-7.
18. Oving IM, Clevers HC. Molecular causes of colon cancer. Eur J Clin Invest 2002;32:448-57.
19. Wielenga VJ, Smits R, Korinek V, Smit L, Kielman M, Fodde R, Clevers H, Pals ST. Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway. Am J Pathol 1999;154:515-23.
20. Sandhu MS, Dunger DB, Giovannucci EL. Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer. J Natl Cancer Inst 2002;94:972-80.
21. Van Beijnum JR, Moerkerk PT, Gerbers AJ, De Bruine AP, Arends JW, Hoogenboom HR, Hufton SE. Target validation for genomics using peptide-specific phage antibodies: a study of five gene products overexpressed in colorectal cancer. Int J Cancer 2002;101:118-27.
22. Guan RJ, Ford HL, Fu Y, Li Y, Shaw LM, Pardee AB. Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer. Cancer Res 2000;60:749-55.
23. Chomez P, De Backer O, Bertrand M, De Plaen E, Boon T, Lucas S. An overview of the MAGE gene family with the identification of all human members of the family. Cancer Res 2001;61:5544-51.
24. Filmus J, Selleck SB. Glypicans: proteoglycans with a surprise. J Clin Invest 2001;108:497-501.
25. Slorach EM, Campbell FC, Dorin JR. A mouse model of intestinal stem cell function and regeneration. J Cell Sci 1999;112 (Pt 18): 3029-38.
26. Brembeck FH, Rustgi AK. The tissue-dependent keratin 19 gene transcription is regulated by GKLF/KLF4 and Sp1. J Biol Chem 2000;275:28230-9.
27. Katz JP, Perreault N, Goldstein BG, Lee CS, Labosky PA, Yang VW, Kaestner KH. The zinc-finger transcription factor Klf4 is required for terminal differentiation of goblet cells in the colon. Development 2002;129:2619-28.
28. Hassan AB, Howell JA. Insulin-like growth factor II supply modifies growth of intestinal adenoma in Apc(Min/+) mice. Cancer Res 2000; 60:1070-6.
29. Abreu MT, Arnold ET, Chow JY, Barrett KE. Phosphatidylinositol 3-kinase-dependent pathways oppose Fas-induced apoptosis and limit chloride secretion in human intestinal epithelial cells. Implications for inflammatory diarrheal states. J Biol Chem 2001;276:47563-74.
30. Beaulieu JF. Integrins and human intestinal cell functions. Front Biosci 1999;4:D310-21.
31. Bjerknes M, Cheng H. Colossal crypts bordering colon adenomas in Apc(Min) mice express full-length Apc. Am J Pathol 1999;154: 1831-4.
32. Gutierrez LS, Suckow M, Lawler J, Ploplis VA, Castellino FJ. Thrombospondin 1-a regulator of adenoma growth and carcinoma progression in the APC(Min/+) mouse model. Carcinogenesis 2003;24:199-207.
33. Marian B. In vitro models for the identification and characterization of tumor-promoting and protective factors for colon carcinogenesis. Food Chem Toxicol 2002;40:1099-104.
34. Shawler DL, Bartholomew RM, Garrett MA, Trauger RJ, Dorigo O, Van Beveren C, Marchese A, Ferre F, Duffy C, Carlo DJ, Sherman LA, Gold DP, et al. Antigenic and immunologic characterization of an allogeneic colon carcinoma vaccine. Clin Exp Immunol 2002;129: 99-106.
35. Lollini PL, Forni G. Antitumor vaccines: is it possible to prevent a tumor? Cancer Immunol Immunother 2002;51:409-16.
36. Lollini PL, De Giovanni C, Nicoletti G, Di Carlo E, Musiani P, Nanni P, Forni G. Immunoprevention of colorectal cancer: a future possibility? Gastroenterol Clin North Am 2002;31:1001-14.